Sinopharm Group Co. Ltd. (1099.HK) stock analysis
In our weekly check, Sinopharm Group Co. Ltd. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 7, red flags: 5.
About Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. is a Healthcare company (Medical - Distribution) based in China, listed on HKSE as 1099.HK.
What our checks show for 1099.HK
Red flags
- Operating profit does not cover the interest bill (1x): interest is paid from cash or new debt.
- The gross margin fell by 1.2 points, to 7.2%: costs are rising faster than prices.
- The net margin is only 1.2%: little room if costs rise.
- The dividend takes 197% of profit: little cushion if profit falls.
- The stock has fallen as much as 67% from a peak. Would you have held through that?
Warning signs
- The net margin fell by 0.2 points over 5 years, to 1.2%: the company keeps less of each sale as profit.
- Analysts expect only about 3% a year of growth in revenue.
- Revenue grew only 1.4% a year over the last 3 years.
- Earnings per share fell 5.7% a year over the last 3 years.
- Net profit fell 5.7% a year over the last 3 years.
- Free cash flow is only 2.2% of revenue.
- The stock is still below its previous peak.
Strengths
- Operating cash flow is 1.98x net profit: the profit arrives as real cash.
- Beta 0.46: the stock usually moves less than the market.
- Actively traded: about 5.3 million shares a day.
- Pay in shares is only 0% of free cash flow.
Similar companies
CAH · COR · SIG.AX · MCK · HSIC
Questions
What grade does Sinopharm Group Co. Ltd. (1099.HK) have?
In our weekly check, Sinopharm Group Co. Ltd. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 7, red flags: 5. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of 1099.HK stock?
This week's biggest flags for Sinopharm Group Co. Ltd.: Weak interest cover, Gross margin falling, Thin margins. In total 12 of 25 checks show a warning or a red flag.
What does Sinopharm Group Co. Ltd. do?
Sinopharm Group Co. Ltd. is a Healthcare company (Medical - Distribution) based in China, listed on HKSE as 1099.HK.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-31
Open the full analysis